November 13 trial: possible suspension due to Abdeslam’s Covid

The trial of the November 13 attacks will resume as scheduled on January 4 but could be suspended for two days due to the Covid-19 contamination of the main accused, Salah Abdeslam, we learned Thursday from a source close to the case, confirming information from France Inter.

The trial is due to resume on January 4 after a two-week break and “may be suspended until the 6th, then resume normally”, according to this source. The interrogations scheduled for January 4 and 5 will be postponed to a later date, a this source clarified. The only survivor of the jihadist commandos which left 130 dead and hundreds injured in Paris and Saint-Denis in November 2015, tested positive for Covid-19 on December 27.

He was held for the duration of the hearing in Fleury-Mérogis prison, south of Paris. Several sources of contamination were detected there and a massive screening of detainees and staff is underway until Monday, according to a union source.

The special assize court has been trying since September 8 and until the end of May 20 defendants, including 14 present at the hearing, suspected of being involved to varying degrees in the preparation of the most deadly jihadist attacks ever perpetrated in France.

Clusters have been identified in several French prisons

The pandemic has already disrupted trials in France, like that of the Charlie Hebdo and Hyper Cacher attacks in 2020.

Briefly interrupted at the end of September after a suspected case, the hearing was suspended for good on October 31, after three cases of contamination among the accused. The break, initially scheduled for two weeks, ended up lasting a month.

Currently, clusters have been identified in several French prisons. At the national level, 370 contaminations were detected among some 70,000 detainees and 448 among the staff (out of about 40,000), according to a report by the ministry established on December 27.

Any reproduction prohibited